Healthcare / Medical Care FacilitiesThailand
$0.24
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $3.5M · quality 43.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
21/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$144M
P/E
N/A
•EV/EBITDA
8.7x
↓ROE
-7.8%
↓Gross Margin
16.0%
↓Debt/Equity
0.98
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-9.9%
FCF CAGR
-60.8%
FCF margin
1.1%
FCF / Net income
-0.20x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $315.3M · net income $-17.9M · FCF $3.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $315.3M | $315.3M | $357.9M | $413.4M | $430.7M |
| Net Income | $-17.9M | $-17.9M | $5.0M | $17.1M | $26.9M |
| EBITDA | $41.5M | $41.5M | $73.0M | $85.9M | $91.8M |
| EPS | -0.03 | -0.03 | 0.01 | 0.03 | 0.04 |
| Gross Margin | 16.0% | 16.0% | 18.7% | 19.6% | 21.6% |
| Operating Margin | 0.3% | 0.3% | 4.0% | 8.1% | 9.4% |
| Net Margin | -5.7% | -5.7% | 1.4% | 4.1% | 6.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.98 | 0.98 | 0.95 | 1.06 | 0.88 |
| Current Ratio | 1.53 | 1.53 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $3.5M | $3.5M | $20.4M | $-57.9M | $58.9M |
| Returns | |||||
| ROE | -7.8% | -7.8% | 2.0% | 6.7% | 11.3% |
| Valuation | |||||
| P/E | — | — | 47.00 | 24.49 | 29.69 |
| EV/EBITDA | 8.71 | 8.71 | 6.85 | 7.89 | 8.82 |
| P/B | 0.63 | 0.63 | 1.12 | 1.74 | 3.00 |
| Growth & Yield | |||||
| Revenue Growth | -11.9% | -11.9% | -13.4% | -4.0% | — |
| EPS Growth | -400.0% | -400.0% | -66.7% | -25.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.8%
Start / end P/E
n/dx → n/dx
EPS bridge
0.01 → -0.03
Residual
-36.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.